title: Supportive measures and finer practice points in 177Lu-DOTATATE PRRT for NET: aiming for optimal disease management.
authors.affiliation: Radiation Medicine Centre (BARC) Jerbai Wadia Rd. Parel, Mumbai 400012, India E-mail: drsanb@yahoo.com.
authors.forename: Sandip
authors.initials: S
authors.lastname: Basu
authors.affiliation: Radiation Medicine Centre (BARC) Jerbai Wadia Rd. Parel, Mumbai 400012, India E-mail: drsanb@yahoo.com.
authors.forename: Vikas
authors.initials: V
authors.lastname: Ostwal
authors.affiliation: Radiation Medicine Centre (BARC) Jerbai Wadia Rd. Parel, Mumbai 400012, India E-mail: drsanb@yahoo.com.
authors.forename: Rohit
authors.initials: R
authors.lastname: Ranade
authors.affiliation: Radiation Medicine Centre (BARC) Jerbai Wadia Rd. Parel, Mumbai 400012, India E-mail: drsanb@yahoo.com.
authors.forename: Dipanjan
authors.initials: D
authors.lastname: Panda
mesh_terms: D019468:Disease Management; D019583:Dose Fractionation, Radiation; D004334:Drug Administration Schedule; D006728:Hormones / Q000378:metabolism; D006801:Humans; D009325:Nausea / Q000517:prevention & control; D009362:Neoplasm Metastasis; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging* / Q000532:radiotherapy*; D009683:Nuclear Medicine / Q000379:methods; D009752:Nutritional Status; D015282:Octreotide / Q000031:analogs & derivatives* / Q000737:chemistry; D009942:Organometallic Compounds / Q000737:chemistry*; D011868:Radioisotopes / Q000627:therapeutic use*; D011877:Radionuclide Imaging; D018000:Receptors, Peptide / Q000737:chemistry*; D014839:Vomiting / Q000517:prevention & control
chemical_list: D006728:Hormones; D009942:Organometallic Compounds; D011868:Radioisotopes; D018000:Receptors, Peptide; C447941:lutetium Lu 177 dotatate; D015282:Octreotide